Physician
Neurology
Dr. Andrew M. Blumenfeld, MD
|
|
Give Review
Doctor Andrew M. Blumenfeld, MD practices Neurology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Andrew Blumenfeld is a published physician. He published 35 publications, including: 'The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache.' He is registered with Medicare.
Publications
- The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache.
- Trigger point injections for Headache disorders: expert consensus methodology and narrative review.
- OnabotulinumtoxinA for the Treatment of Headache.
- OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute Headache medication overuse at baseline.
- Glossopharyngeal neuralgia.
- Headache-related health resource utilisation in chronic and episodic migraine across six countries.
- Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches - A Narrative Review.
- Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of...
- Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS).
- A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic Migraine.
- Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic Migraine.
- Botulinum neurotoxin for the treatment of migraine and other primary Headache disorders.
- An integrated management program for Migraine: the Kaiser experience.
- Procedures for administering botulinum toxin type A for migraine and tension-type Headache.
- The International Burden of Migraine Study (IBMS): Study design, methodology, and baseline cohort characteristics.
- Patterns of use of peripheral nerve blocks and trigger point injections among Headache practitioners in the USA: Results of the American Headache Society Interventiona...
- Disability, HRQoL and resource use among chronic and episodic Migraineurs: results from the International Burden of Migraine Study (IBMS).
- Method of injection of onabotulinumtoxinA for chronic Migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
- Pure tension-type Headache versus tension-type Headache in the migraineur.
- Botulinum toxin injections for Headache.
- Burden of illness and satisfaction with care among patients with Headache seen in a primary care setting.
- Botulinum toxin type A for the treatment of Headache: pro.
- Botulinum toxin type A as an effective prophylactic treatment in primary Headache disorders.
- Center of excellence for Headache care: group model at Kaiser Permanente.
- Bruxism, temporomandibular dysfunction, tension type Headache, and migraine: a comment.
- The Headache management trial: a randomized study of coordinated care.
- A combination of riboflavin, magnesium, and feverfew for Migraine prophylaxis: a randomized trial.
- A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for Migraine prophylaxis.
- Peripheral nerve blocks and trigger point injections in headache management - a Systematic review and suggestions for future research.
- Does single-file botox injection really work for primary Headache?
- OnabotulinumtoxinA for Chronic Migraine.
- Nerve blocks, trigger point injections and Headache.
- Adjunctive therapy with bromocriptine in Parkinson''s Disease.
- Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in Multiple sclerosis: a two centre phase 2 study.
Schools
University Of The Witwatersrand Faculty Of Health Sciences
University Mass Med School
Procedures Preformed
- Nerve Block, Somatic
- Non-Cosmetic Chemodenervation
Conditions Treated
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Cerebral Artery Thrombosis
- Cerebral Hemorrhage
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Massachusetts -
University of the Witwatersrand
Drug Facts
| NPI NUMBER | 1164459913 | |
| NPPES Provider LastName | BLUMENFELD | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 920245138 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 589.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164459913 |
| Last Name Of The Provider | BLUMENFELD |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
|
Dr. Michael J. Zupancic, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin M. Frishberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark N. Sadoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irene J. Oh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cordia Y. Wan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary A. Kalafut, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anchi Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eva L. Sorensen, MD
This Doctor is OpenDoctor Recommended.
|